Stroke Local Pharmacy Group meeting 7 th May 2013 Dr. Lucy Sykes.

Slides:



Advertisements
Similar presentations
Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
Advertisements

New Atrial Fibrillation/Flutter Pathway and GRASP Tool
1 GRASP-AF Audit - Intro 8 th July 2010 Mark Gregory.
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
Emergency/Urgent Referral* (3) -Pt acutely unwell with palpitations -Pt with haemodyanically unstable acute onset AF -2 nd /3 rd heart block -Exercise.
Preventing Strokes One at a Time Acute Interventions and Management 2009.
Atrial fibrillation Cardiology #2 Gimadeeva A.D..
Management of Stroke and Transient Ischaemic Attack Sam Thomson.
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
Stroke Mark Sudlow Consultant and Senior Lecturer
Atrial fibrillation.
Drugs for Dysrhythmias 19. Learning Outcomes 1. Explain how rhythm abnormalities can affect cardiac function. 2. Illustrate the flow of electrical impulses.
STROKE: 911 Emergency Learning Objectives for Stroke: 911 Emergency When you finish this course you will be able to answer the following questions: Where.
STROKE Dr Muhammah Ashraf Assistant Professor Medicine
ATRIAL FIBRILLATION Linda A. Snyder, MSN, CRNP. Definition: A common arrhythmia characterized by chaotic, rapid, discontinuous atrial depolarizations.
ARISTOTLE TRIAL Dr R Nyabadza GPST1 Ward 32. Structure AF, stroke and CHA 2 -DS 2 VASC Anticoagulant choices ARISTOTLE trial Cost NICE guidance and the.
AF and NOACs An UPDATE JULY 2014
Stroke – acute hemiplegia. History Sandeep Patel is a 75 year old retired lawyer who has been admitted to MAU following a sudden onset of left sided weakness.
Atrial fibrillation wavelets propagating in different directions disorganised atrial depolarisation without effective atrial contraction f waves
Atrial fibrillation Daniel Gutenberger M.D. Chief Medical Director American General, Milwaukee.
By: Mark Torres Anatomy and Physiology II TR 3:15- 6:00.
Arrhythmias: The Good, the Bad and the Ugly
Atrial Fibrillation Steve McGlynn
Atrial Fibrillation Steve McGlynn Specialist Principal Pharmacist (Cardiology), Greater Glasgow and Clyde Honorary Clinical Lecture, University of Strathclyde.
Priyanca Patel and Fil Sianos
Atrial Fibrillation. Statistics 1.5% of people over 65 have AF 1.5% of people over 65 have AF 5x increased risk of stroke 5x increased risk of stroke.
Stroke 101 Goals of Presentation What is a stroke? Types of stroke Warning signs of stroke Why did I have a stroke? Are there treatments for stroke?
All rights reserved. This document contains the confidential and proprietary information of Innovate Research and Development and its affiliates, and any.
DR ABUL AZIM CONSULTANT IN ELDERLY MEDICINE & STROKE STROKE AND ATRIAL FIBRILLATION AND THE ROLE OF THE NOAC.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
MANAGEMENT OF STROKE.
Dr Avinash Haridas Pillai
Consultant Neurologist,
Secondary prevention after a TIA or ischemic stroke.
European Heart Journal 2010 European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Atrial Fibrillation Current Management Strategies.
STROKE BY : Shanak Nouha cleudiane.  Definition of stroke  Types  Symptoms  Fast test  Causes  Warning signs  Prevention  Treatment  Summary.
Preventing Strokes One at a Time Putting It All Together 2009.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Update in ESC: Dabigatran among OAC
Adult Medical-Surgical Nursing Neurology Module: Cerebrovascular Disease I (TIA)
Update on TIA Kath Pasco October  Primary prevention has been effective in fall in incidence of first stroke  Major improvements still required.
What is a stroke? A stroke occurs when an artery supplying the brain either blocks or bursts.
Treatment of Atrial Fibrillation M Samson – PGY-2 Riverside Campus July 17, 2015 Academic Day.
Case study - patient presenting with newly diagnosed NVAF with prior CAD Full Prescribing Information is provided at the end of this presentation EUAPI581k;
Is there a future role for warfarin in stroke prevention for NVAF in 2014 EUAPI581f, April 2014 Full Prescribing Information is provided at the end of.
Lifestyle Diseases Heart Attack, Stroke & Diabetes Mrs. Lashmet Health.
Cerebrovascular disease Dr.Nathasha Luke Epidemiology 3rd leading cause of death and disability in the world 3rd leading cause of death and disability.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Brain waves or brain drain Interactive case discussion Dr Jenny Vaughan and Dr Richard Perry Charing Cross Hospital Hammersmith Hospital Imperial College.
Antithrombotic Therapy in Atrial Fibrillation Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention of Thrombosis,
Stroke Dr Jane Molloy – Clinical Lead Stroke Services SRFT.
Atrial Fibrillation: An old age problem PCCS Village Hotel 18 th May 2011.
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Simon Howard Medical Management of Acute Stroke. Fast Recognition of Stroke With sudden onset neurological symptoms: 'FAST' should be used to screen for.
Prevention of thromboembolism in AF ACC/AHA/ESC Guidelines Jin-Bae Kim, MD, PhD Arrhythmia Service, Division of Cardiology Cardiovascular Center, Kyung.
Anticoagulation in Atrial Fibrillation Dalia Hawwass PGY2 June 2015.
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
IN THE NAME OF GOD Dr. h-kayalha Anesthesiologist.
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
Life after a Cardiovascular Event
Atrial fibrillation (AF) and flutter
Stroke secondary prevention
NICE 2014 Check pulse in patients presenting with:
Presentation transcript:

Stroke Local Pharmacy Group meeting 7 th May 2013 Dr. Lucy Sykes

Outline Overview of stroke Case presentation Risk factors Atrial fibrillation Targets Treatment options TIA Resources

What is a stroke? Focal neurological deficit > 24 hrs 2/3 infarction, 1/3 haemorrhage (UK) 3 rd leading cause death in UK (11%) Significant cause of major disability Risk recurrence within 5 yrs ~ 40%

Risk factors High BP High cholesterol Diabetes (DM) Smoking Atrial fibrillation Previous or family history

A case 95 year old lady Sudden onset whilst watching TV Right arm / leg weakness Slurred speech Headache Daughter did FAST test = positive

Arrived in ED Seen by stroke consultant & nurse Considered for thrombolysis CT brain showed no bleed Not for thrombolysis as >4.5 hours since time of onset Transferred to stroke unit

Standard acute stroke treatment Aspirin 300mg od 2/52 Then clopidogrel 75mg od long term Control risk factors (BP, diabetes, chol) Life-style advice (smoking, diet, exercise) Look for cause of stroke

TOAST Classification 1Large artery atherosclerosis 2Cardioembolism 3Small vessel occlusion (lacunar) 4Other determined aetiology 5Undetermined aetiology

Investigations Fasting chol & glucose ECG / 24 hour tape Echocardiogram USS doppler neck arteries

Results 1 BP 200/110 (target is 130/80) Not diabetic (target in DM is glu 4-11) High chol 6.2 (target is chol <4, LDL <2)

Treatment options 1 BP –Evidence for all antihypertensives in stroke –Target BP is most important thing –Choice depends on SE profile ACE-i or A2RB Ca2+ channel blockers B-blockers

Treatment options 2 Cholesterol –Statins = main-stay of therapy –Benefits even if normal chol (plaque stability) –Rosuva good for those with myositis Diabetes –Usual diabetic treatment options –SU, metformin, gliptins, insulins

Results 2 24 hour ECG - paroxysmal AF Echo – good cardiac funct, enlarged LA Neck arteries – no stenosis

ECG Normal sinus rhythm –Normal heart rate –Regular rhythm –P waves –Steady baseline AF –Heart rate increased (tachyarrhythmia)* –Irregularly irregular rhythm –No P wave P Ashley EA,Niebauer J. Cardiology Explained. Remedica: London 2004 *Reduced heart rate (bradyarrhythmia) may also be observed Regular rhythm Irregularly irregular rhythm

Why does AF matter? Symptoms –Palpitations –Chest pain –Breathlessness –Reduced exercise tolerance Complications –Risk of clot formation, i.e. risk of embolus to brain or elsewhere in body

Stroke risk in AF

Rate vs. rhythm Prevent fast / slow rates vs. Correct back into sinus rhythm Both effective at improving –Mortality –Stroke risk –Symptoms –Quality of life

Treatment options for AF Adapted from Prystowsky EN. Am J Cardiol 2000;85:3D–11D. STROKE PREVENTION Vitamin K antagonists (e.g. warfarin) Aspirin / clopidogrel Dabigatran etexilate Rivaroxaban Apixaban PHARMACOLOGICAL Removal/isolation of left atrial appendage NON-PHARMACOLOGICAL Anti-arrhythmic drugs – Class IA – Class IC – Class III MAINTENANCE OF SINUS RHYTHM PHARMACOLOGICAL Ablation Surgery (MAZE procedure) NON-PHARMACOLOGICAL CONTROL OF HEART RATE  -blockers Calcium channel blockers (non-DHP) Digoxin PHARMACOLOGICAL Ablation/permanent pacing NON-PHARMACOLOGICAL DHP = dihydropyridine

Which treatment for AF? CHADS 2 < 2nothing CHADS 2 > 2warfarin / NOAC CHADS 2 scoreAnnual stroke risk %

CHADS 2 = 2? CHA 2 DS 2 VASc ConditionPoints CCongestive cardiac failure1 HHypertension (> 140/90)1 A2A2 Age ≥ 742 DDiabetes1 S2S2 Previous stroke / TIA / VTE2 VOther vascular disease1 AAge ScSex category (female)1

CHA 2 DS 2 VASc = 0nothing CHA 2 DS 2 VASc = 1warfarin / NOAC CHA 2 DS 2 VASc ≥ 2warfarin / NOAC CHA 2 DS 2 VAScAnnual Stroke Risk %

Warfarin Target INR in AF 2-3 Time in therapeutic range >72%

TIA (mini-stroke) Focal neurological deficit < 24 hrs –in practice < 1hr Treatment essentially same as for stroke –Warning of high stroke risk Urgent referral to TIA clinic Risk factors & investigations same

TIA treatment CT scanning - ? bleed –If no bleed give clopidogrel 300mg stat then 75mg od US doppler neck arteries - ? Stenosis >50% –If pos need urgent vascular surgical review ECG - ? AF –If pos need urgent anticoag with warf + clex or NOAC (anticoag instead of clop) Other investigations as OP

Key messages TIA & stroke essentially the same –Both need urgent medical attention FAST Look for a cause Manage risk factors & meet targets

Useful resources –The Stroke Association –For professionals & patients –> ‘resources’ –> ‘changes to RCP guidelines for stroke 2012’